Pfizer claimed the pharmaceutical industry’s latest big prize Monday, beating out a group of rivals after months of jockeying to buy Medivation and its blockbuster cancer drug for $14 billion. Bloomberg's Jeffrey McCracken and Drew Armstrong report on "Bloomberg Markets." (Source: Bloomberg)